These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10554016)

  • 21. [Real-time quantitative PCR assay of Epstein-Barr virus in whole blood cells of nasopharyngeal carcinoma patients].
    Wang H; Deng L; Chen SH; Wang SQ; Cao Y
    Shi Yan Sheng Wu Xue Bao; 2003 Feb; 36(1):32-6. PubMed ID: 12751207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum/plasma viral DNA: mechanisms and diagnostic applications to nasopharyngeal and cervical carcinoma.
    Mutirangura A
    Ann N Y Acad Sci; 2001 Sep; 945():59-67. PubMed ID: 11708495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation between the kinetics of plasma EBV DNA levels and clinical response during treatment in patients with nasopharyngeal carcinoma].
    Peng PJ; Zhao C; Liao H; Wang FQ; Zhang L
    Ai Zheng; 2002 Aug; 21(8):817-22. PubMed ID: 12478884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic and prognostic implications of circulating cell-free Epstein-Barr virus DNA in natural killer/T-cell lymphoma.
    Lei KI; Chan LY; Chan WY; Johnson PJ; Lo YM
    Clin Cancer Res; 2002 Jan; 8(1):29-34. PubMed ID: 11801537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
    Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
    Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients.
    Hassen E; Farhat K; Gabbouj S; Bouaouina N; Abdelaziz H; Chouchane L
    Biomarkers; 2011 May; 16(3):274-80. PubMed ID: 21506698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical role of circulating Epstein-Barr virus DNA as a tumor marker in lymphoepithelioma-like carcinoma of the lung.
    Ngan RK; Yip TT; Cheng WW; Chan JK; Cho WC; Ma VW; Wan KK; Au JS; Law CK
    Ann N Y Acad Sci; 2004 Jun; 1022():263-70. PubMed ID: 15251971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparity of sensitivities in detection of radiation-naïve and postirradiation recurrent nasopharyngeal carcinoma of the undifferentiated type by quantitative analysis of circulating Epstein-Barr virus DNA1,2.
    Leung SF; Lo YM; Chan AT; To KF; To E; Chan LY; Zee B; Huang DP; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3431-4. PubMed ID: 12960133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
    Tong JH; Tsang RK; Lo KW; Woo JK; Kwong J; Chan MW; Chang AR; van Hasselt CA; Huang DP; To KF
    Clin Cancer Res; 2002 Aug; 8(8):2612-9. PubMed ID: 12171892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA.
    Lo YM; Chan AT; Chan LY; Leung SF; Lam CW; Huang DP; Johnson PJ
    Cancer Res; 2000 Dec; 60(24):6878-81. PubMed ID: 11156384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy.
    An X; Wang FH; Ding PR; Deng L; Jiang WQ; Zhang L; Shao JY; Li YH
    Cancer; 2011 Aug; 117(16):3750-7. PubMed ID: 21319149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
    Tsai ST; Jin YT; Mann RB; Ambinder RF
    Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical value of quantitative analysis of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma].
    Yuan H; Yang BB; Xu ZF
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):162-5. PubMed ID: 15283296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma.
    Tsang NM; Chuang CC; Tseng CK; Hao SP; Kuo TT; Lin CY; Pai PC
    Cancer; 2003 Dec; 98(11):2385-92. PubMed ID: 14635073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma.
    Mutirangura A; Pornthanakasem W; Theamboonlers A; Sriuranpong V; Lertsanguansinchi P; Yenrudi S; Voravud N; Supiyaphun P; Poovorawan Y
    Clin Cancer Res; 1998 Mar; 4(3):665-9. PubMed ID: 9533535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease.
    Ngan RK; Yip TT; Cheng WW; Chan JK; Cho WC; Ma VW; Wan KK; Au SK; Law CK; Lau WH
    Clin Cancer Res; 2002 Apr; 8(4):986-94. PubMed ID: 11948104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma.
    Yip TT; Ngan RK; Fong AH; Law SC
    Oral Oncol; 2014 Jun; 50(6):527-38. PubMed ID: 24440146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma.
    Leung SF; Zee B; Ma BB; Hui EP; Mo F; Lai M; Chan KC; Chan LY; Kwan WH; Lo YM; Chan AT
    J Clin Oncol; 2006 Dec; 24(34):5414-8. PubMed ID: 17135642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.